Sava Technologies, a London-based HealthTech company developing a wearable biosensor platform that detects molecules just beneath the skin, today announced a €32.08 million ($36 million) Series B round to fund…
London’s Sava raises €32.08 million and partners with Ascensia to bring its glucose microsensor to Europe
What they do:
Redcliffe Labs is India's Largest Omni-channel Diagnostics platform
Quick facts:
What they do:
India's Fastest Diagnostics Service
Quick facts:
What they do:
Building Clinical Superintelligence.
Quick facts:
HQ: San Francisco, CA, United States
What they do:
Enabling health professionals to prescribe clinical-grade wellness…
Quick facts:
HQ: Athens, Greece
What they do:
Robotic Automation for cancer diagnostics - Robotic Microscopes &…
Quick facts:
What they do:
BBy powders breast milk that's immunologically active & lasts 6 months
Quick facts:
HQ: New York, NY, United States
Sava Technologies, a London-based HealthTech company developing a wearable biosensor platform that detects molecules just beneath the skin, today announced a €32.08 million ($36 million) Series B round to fund…
London, United Kingdom
Latest round: €32.1M Series B (Oct 2026).
Similar startups: Redcliffe Lifetech, Orange Health Labs, and Eden.